326 related articles for article (PubMed ID: 4064843)
121. Quantitative analysis of spermatogenic DNA synthesis in the rat using a monoclonal anti-5-bromodeoxyuridine antibody.
Shirataki S; Takihara H; Imoto K; Kamada K; Baba Y; Naito K
Andrologia; 1994; 26(6):343-9. PubMed ID: 7872509
[TBL] [Abstract][Full Text] [Related]
122. In vivo administration of bromodeoxyuridine and flow cytometry for cell kinetic studies in human malignancies.
Danova M; Wilson G; Riccardi A; Mazzini G; Ucci G; Giordano M; Brugnatelli S; Luoni R; McNally NJ; Ascari E
Haematologica; 1987; 72(2):115-9. PubMed ID: 3114066
[No Abstract] [Full Text] [Related]
123. Bromodeoxyuridine-mediated radiosensitization in human glioma: the effect of concentration, duration, and fluoropyrimidine modulation.
McLaughlin PW; Lawrence TS; Seabury H; Nguyen N; Stetson PL; Greenberg HS; Mancini WR
Int J Radiat Oncol Biol Phys; 1994 Oct; 30(3):601-7. PubMed ID: 7928491
[TBL] [Abstract][Full Text] [Related]
124. Lewis lung carcinoma and two transplantable sarcomas in mice as experimental therapy models: biological characteristics and cell population kinetics.
Gasińska A; Niezabitowski A; Uniwersałl B; Wasilewska A; Lackowska B
Folia Histochem Cytobiol; 1997; 35(3):165-73. PubMed ID: 9276345
[TBL] [Abstract][Full Text] [Related]
125. Studies with anti-bromodeoxyuridine antibodies: II. Simultaneous immunocytochemical detection of antigen expression and DNA synthesis by in vivo labeling of mouse intestinal mucosa.
Schutte B; Reynders MM; Bosman FT; Blijham GH
J Histochem Cytochem; 1987 Mar; 35(3):371-4. PubMed ID: 3546484
[TBL] [Abstract][Full Text] [Related]
126. Increase in the fraction of necrotic, not apoptotic, cells in SiHa xenograft tumours shortly after irradiation.
Olive PL; Vikse CM; Vanderbyl S
Radiother Oncol; 1999 Jan; 50(1):113-9. PubMed ID: 10225565
[TBL] [Abstract][Full Text] [Related]
127. Flow cytometry: general principles and applications to selected studies in tumor biology.
Sugarbaker EV; Thornthwaite JT; Temple WT; Ketcham AS
Int Adv Surg Oncol; 1979; 2():125-53. PubMed ID: 95452
[TBL] [Abstract][Full Text] [Related]
128. Double labelling of cells with tritiated thymidine and bromodeoxyuridine reveals a circadian rhythm-dependent variation in duration of DNA synthesis and S phase flux rates in rodent oral epithelium.
Hume WJ; Thompson J
Cell Tissue Kinet; 1990 Jul; 23(4):313-23. PubMed ID: 2202516
[TBL] [Abstract][Full Text] [Related]
129. Proliferative changes in two murine tumours in response to single or fractionated doses of X-rays.
Wilson GD; Martindale CA; Soranson JA; Carl UM; McNally NJ
Cell Prolif; 1992 Sep; 25(5):415-30. PubMed ID: 1391229
[TBL] [Abstract][Full Text] [Related]
130. DNA-synthesizing cells in oral epithelium have a range of cell cycle durations: evidence from double-labelling studies using tritiated thymidine and bromodeoxyuridine.
Hume WJ
Cell Tissue Kinet; 1989 Sep; 22(5):377-82. PubMed ID: 2611853
[TBL] [Abstract][Full Text] [Related]
131. Flow cytometric bromodeoxyuridine/DNA analysis of hyperthermia and/or adriamycin for human pancreatic adenocarcinoma cell line Capan-2.
Nakata B; Chung YS; Yokomatsu H; Sawada T; Kubo T; Kondo Y; Satake K; Sowa M
Jpn J Cancer Res; 1992 May; 83(5):477-82. PubMed ID: 1618697
[TBL] [Abstract][Full Text] [Related]
132. Flow cytometry as a tool for the prognostic assessment of human neoplasia.
Mauro F; Teodori L; Schumann J; Göhde W
Int J Radiat Oncol Biol Phys; 1986 Apr; 12(4):625-36. PubMed ID: 3700167
[TBL] [Abstract][Full Text] [Related]
133. An improved immunocytochemical procedure for high-sensitivity detection of incorporated bromodeoxyuridine.
Beisker W; Dolbeare F; Gray JW
Cytometry; 1987 Mar; 8(2):235-9. PubMed ID: 3582069
[TBL] [Abstract][Full Text] [Related]
134. Cell proliferation and differentiation in squamous cancer.
Dische S; Saunders MI; Bennett MH; Wilson GD; McNally NJ
Radiother Oncol; 1989 May; 15(1):19-23. PubMed ID: 2748939
[TBL] [Abstract][Full Text] [Related]
135. The effect of section thickness and embedding media on the observed S-phase labelling index of artificially selected cell populations from neonatal mouse liver and spleen.
Monkhouse WS
J Anat; 1985 Aug; 141():201-9. PubMed ID: 3908424
[TBL] [Abstract][Full Text] [Related]
136. Tissue-specific pharmacodynamics of 5-bromo-2'-deoxyuridine incorporation into DNA in VX2 tumor-bearing rabbits.
Stetson PL; Maybaum J; Wagner JG; Averill DR; Wollner IS; Knol JA; Johnson NJ; Yang ZM; Preiskorn D; Smith P
Cancer Res; 1988 Dec; 48(23):6900-5. PubMed ID: 3180098
[TBL] [Abstract][Full Text] [Related]
137. Ki-67 expression and BrdUrd incorporation as markers of proliferative activity in human prostate tumour models.
van Weerden WM; Moerings EP; van Kreuningen A; de Jong FH; van Steenbrugge GJ; Schröder FH
Cell Prolif; 1993 Jan; 26(1):67-75. PubMed ID: 8439590
[TBL] [Abstract][Full Text] [Related]
138. Cell proliferation in the subependymal layer of the adult mouse in vivo and in vitro.
Hauke C; Ackermann I; Korr H
Cell Prolif; 1995 Nov; 28(11):595-607. PubMed ID: 8555372
[TBL] [Abstract][Full Text] [Related]
139. Utility and sensitivity of anti BrdU antibodies in assessing S-phase cells compared to autoradiography.
Raza A; Ucar K; Bhayana R; Kempski M; Preisler HD
Cell Biochem Funct; 1985 Apr; 3(2):149-53. PubMed ID: 3915232
[TBL] [Abstract][Full Text] [Related]
140. On the mechanism of 5-bromodeoxyuridine induction of prolactin synthesis in rat pituitary tumor cells.
Biswas DK; Abdullah KT; Brennessel BA
J Cell Biol; 1979 Apr; 81(1):1-9. PubMed ID: 479283
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
